Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Viruses ; 11(3)2019 03 01.
Article in English | MEDLINE | ID: mdl-30832223

ABSTRACT

Filoviruses, such as Ebola virus (EBOV) and Marburg virus, are causative agents of unpredictable outbreaks of severe hemorrhagic fevers in humans and non-human primates. For infection, filoviral particles need to be internalized and delivered to intracellular vesicles containing cathepsin proteases and the viral receptor Niemann-Pick C1. Previous studies have shown that EBOV triggers macropinocytosis of the viral particles in a glycoprotein (GP)-dependent manner, but the molecular events required for filovirus internalization remain mostly unknown. Here we report that the diacylglycerol kinase inhibitor, R-59-022, blocks EBOV GP-mediated entry into Vero cells and bone marrow-derived macrophages. Investigation of the mode of action of the inhibitor revealed that it blocked an early step in entry, more specifically, the internalization of the viral particles via macropinocytosis. Finally, R-59-022 blocked viral entry mediated by a panel of pathogenic filovirus GPs and inhibited growth of replicative Ebola virus. Taken together, our studies suggest that R-59-022 could be used as a tool to investigate macropinocytic uptake of filoviruses and could be a starting point for the development of pan-filoviral therapeutics.


Subject(s)
Diacylglycerol Kinase/antagonists & inhibitors , Filoviridae/drug effects , Filoviridae/physiology , Pyrimidinones/pharmacology , Thiazoles/pharmacology , Virus Internalization/drug effects , Animals , Chlorocebus aethiops , Ebolavirus/physiology , HEK293 Cells , Humans , Macrophages/virology , Marburgvirus/physiology , Pinocytosis/drug effects , Receptors, Virus , Vero Cells , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...